To define the clinical relevance of SQLE-regulated NF-κB signaling and BIRC3 expression, we performed IHC analysis in tumor tissues from CRC patients with anti-SQLE, anti-IκBα and anti-BIRC3 antibodies. This evidence concerns the gene BIRC3 and colorectal carcinoma.